Literature DB >> 9460298

Condyloma acuminatum: its histopathological pattern.

E P Dias1, A L Gouvêa, C C Eyer.   

Abstract

Condyloma acuminatum is one of the clinical manifestations of papillomavirus infection. The classical histopathological features are already known and do not constitute a diagnostic problem. Clinically, it has been classified into growth or proliferative, full-expression, and regressive or persistent phases, with the histopathological aspects of these distinct phases being well documented in equine cutaneous papillomas. We have designed a protocol of histopathological analysis in order to investigate the possibility of identifying the evolutional phases in human condylomata acuminata. Sixty condylomata acuminata from the files of the Department of Pathology, Universidade Federal Fluminense, were studied regarding koilocytosis, paraceratosis, acantosis, basal cell hyperplasia and mononuclear cell infiltrate. After an individual analysis and comparison of the cases, the main differential aspects of condyloma acuminatum were: koilocytosis, transepithelial lymphocytic infiltrate and basal cell hyperplasia. Thus, condylomatous lesions can be histopathological differentiated in three major patterns: proliferative, viral replication activity and regressive.

Entities:  

Mesh:

Year:  1997        PMID: 9460298     DOI: 10.1590/s1516-31801997000200003

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  3 in total

1.  Condyloma acuminatum associated with odontogenic myxoma: a case report.

Authors:  G Rajasekhar; Mohammed Mushtaq; Nanda Gopal Vura; Ravi Shekar; Sravan Kumar
Journal:  J Maxillofac Oral Surg       Date:  2010-04-24

2.  Oral condyloma acuminatum with changes in excretory duct of minor salivary gland: An unusual case report and review of literature.

Authors:  Himani Tiwari Chaturvedi; Chandrashekher Chaturevedi
Journal:  J Oral Maxillofac Pathol       Date:  2021-01-09

3.  Results of phase 2 trials exploring the safety and efficacy of omiganan in patients with human papillomavirus-induced genital lesions.

Authors:  Melanie Rijsbergen; Rianne Rijneveld; Marina Todd; Gary L Feiss; Stijn T P Kouwenhoven; Koen D Quint; Dirk C J G van Alewijk; Maurits N C de Koning; Erica S Klaassen; Jacobus Burggraaf; Robert Rissmann; Mariëtte I E van Poelgeest
Journal:  Br J Clin Pharmacol       Date:  2020-09-28       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.